Review: taking Venlafaxine hydrochloride and Amphetamine salt combo together


Summary

Drug interactions are reported among people who take Venlafaxine hydrochloride and Amphetamine salt combo together. This review analyzes the effectiveness and drug interactions between Venlafaxine hydrochloride and Amphetamine salt combo. It is created by eHealthMe based on reports of 965 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Venlafaxine hydrochloride and Amphetamine salt combo >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Venlafaxine Hydrochloride

Venlafaxine hydrochloride has active ingredients of venlafaxine hydrochloride. It is often used in depression. (latest outcomes from Venlafaxine hydrochloride 4,408 users)

Amphetamine Salt Combo

Amphetamine salt combo has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Amphetamine salt combo 385 users)

On Aug, 23, 2016

965 people who take Venlafaxine Hydrochloride, Amphetamine Salt Combo are studied.


Number of reports submitted per year:

Venlafaxine hydrochloride and Amphetamine salt combo drug interactions.

Drug effectiveness over time:

Venlafaxine Hydrochloride:
  • < 1 month: 6.0% - (1 of 16 people)
  • 1 - 6 months: 20.0% - (4 of 20 people)
  • 6 - 12 months: 16.0% - (6 of 36 people)
  • 1 - 2 years: 41.0% - (14 of 34 people)
  • 2 - 5 years: 33.0% - (18 of 53 people)
  • 5 - 10 years: 40.0% - (12 of 30 people)
  • 10+ years: 41.0% - (7 of 17 people)
  • not specified: 50.0% - (1 of 2 people)
Amphetamine Salt Combo:
  • < 1 month: 33.0% - (4 of 12 people)
  • 1 - 6 months: 48.0% - (21 of 43 people)
  • 6 - 12 months: 51.0% - (15 of 29 people)
  • 1 - 2 years: 67.0% - (33 of 49 people)
  • 2 - 5 years: 56.0% - (25 of 44 people)
  • 5 - 10 years: 48.0% - (12 of 25 people)
  • 10+ years: 80.0% - (8 of 10 people)
  • not specified: 33.0% - (1 of 3 people)

Drug effectiveness by gender:

Venlafaxine Hydrochloride:
  • female: 32.0% - (51 of 159 people)
  • male: 24.0% - (12 of 49 people)
Amphetamine Salt Combo:
  • female: 54.0% - (89 of 164 people)
  • male: 58.0% - (30 of 51 people)

Drug effectiveness by age:

Venlafaxine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 20.0% - (1 of 5 people)
  • 20-29: 37.0% - (21 of 56 people)
  • 30-39: 20.0% - (11 of 54 people)
  • 40-49: 35.0% - (19 of 54 people)
  • 50-59: 31.0% - (10 of 32 people)
  • 60+: 14.0% - (1 of 7 people)
Amphetamine Salt Combo:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 28.0% - (2 of 7 people)
  • 20-29: 63.0% - (36 of 57 people)
  • 30-39: 51.0% - (30 of 58 people)
  • 40-49: 51.0% - (28 of 54 people)
  • 50-59: 56.0% - (18 of 32 people)
  • 60+: 71.0% - (5 of 7 people)

Most common drug interactions over time *:

< 1 month:
  • vomiting
  • depression
  • feeling abnormal
  • intentional overdose
  • suicide attempt
  • suicidal ideation
  • anxiety
  • blindness
  • confusional state
  • dizziness
1 - 6 months:
  • death
  • hair growth abnormal
  • chest pain
  • insomnia
  • nausea
  • vision problems
  • anxiety
  • apathy
  • breathing-related sleep disorder
  • burning sensation
6 - 12 months:
  • anxiety
  • depression
  • memory impairment
  • arthralgia
  • back pain
  • disturbance in attention
  • myalgia
  • breast cancer
  • breast cancer in situ
  • breast cyst
1 - 2 years:
  • anxiety
  • fatigue
  • sweating - excessive
  • mood swings
  • headache
  • obesity
  • adrenal glands
  • amenorrhoea
  • diarrhea
  • eczema eyelids
2 - 5 years:
  • sweating - excessive
  • fatigue
  • weight gain
  • anxiety
  • constipation
  • feeling jittery
  • hair growth abnormal
  • nausea
  • chest pain
  • dyspnoea
5 - 10 years:
  • depression
  • headache
  • chest pain
  • memory impairment
  • anxiety
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • itching
  • migraine
  • breathing-related sleep disorder
  • burning sensation
10+ years:
  • erectile dysfunction
  • anxiety
  • constipation
  • depression
  • dry mouth
  • dyshidrotic eczema
  • dysphoria
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • panic attack
  • personality change
not specified:
  • fatigue
  • depression
  • anxiety
  • nausea
  • pain
  • insomnia
  • feeling abnormal
  • somnolence
  • chest pain
  • fall

Most common drug interactions by gender *:

female:
  • anxiety
  • depression
  • fatigue
  • nausea
  • chest pain
  • insomnia
  • pain
  • feeling abnormal
  • drug ineffective
  • fall
male:
  • headache
  • somnolence
  • anxiety
  • bite
  • thirst
  • psychomotor hyperactivity
  • depression
  • fatigue
  • nausea
  • pain

Most common drug interactions by age *:

2-9:
  • aggression
  • agitation
  • bipolar disorder
  • bite
  • convulsion
  • depression
  • homicidal ideation
  • intentional self-injury
  • screaming
  • staring
10-19:
  • psychomotor hyperactivity
  • thirst
  • multi-organ failure
  • depression
  • pulmonary embolism
  • bite
  • cardiopulmonary failure
  • compulsions
  • hyperglycaemia
  • protrusion tongue
20-29:
  • anxiety
  • feeling abnormal
  • drug withdrawal syndrome
  • depression
  • nausea
  • fatigue
  • pain
  • aggression
  • apathy
  • drug ineffective
30-39:
  • anxiety
  • feeling abnormal
  • blood glucose increased
  • insomnia
  • headache
  • palpitations
  • abdominal pain upper
  • body temperature increased
  • device dislocation
  • diabetes mellitus inadequate control
40-49:
  • fatigue
  • chest discomfort
  • chest pain
  • pyrexia
  • palpitations
  • cough
  • insomnia
  • cardiomegaly
  • dilatation ventricular
  • dyspnoea exertional
50-59:
  • nausea
  • depression
  • anxiety
  • back pain
  • fall
  • pain
  • fatigue
  • chest pain
  • insomnia
  • gait disturbance
60+:
  • fatigue
  • oedema peripheral
  • pain
  • rash
  • completed suicide
  • malaise
  • headache
  • chills
  • drug ineffective
  • gastrointestinal disorder

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Venlafaxine hydrochloride and Amphetamine salt combo?

Can you answer these questions?

More questions for: Venlafaxine hydrochloride, Amphetamine salt combo

You may be interested in these reviews

More reviews for: Venlafaxine hydrochloride, Amphetamine salt combo

On eHealthMe, Venlafaxine hydrochloride (venlafaxine hydrochloride) is often used to treat depression. Amphetamine salt combo (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.